Literature DB >> 31467125

Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient.

Sarolta Bojtine Kovacs1, Jingting Luan1, Sandra Maria Dold1,2, Andreas Weis1,3, Milena Pantic1, Justus Duyster1,3, Ralph Wäsch1,3, Monika Engelhardt4,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31467125      PMCID： PMC7049367          DOI： 10.3324/haematol.2019.232330

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Amplification of IGH/CCND1 fusion gene in a primary plasma cell leukemia case.

Authors:  Tomohiro Ishigaki; Kouji Sasaki; Ken Watanabe; Norihiko Nakamura; Shigeo Toyota; Hirofumi Kobayashi; Shuji Tohda
Journal:  Cancer Genet Cytogenet       Date:  2010-08

2.  Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.

Authors:  Ralph Wäsch; Thilo Jakob; Kristin Technau; Jürgen Finke; Monika Engelhardt
Journal:  Ann Hematol       Date:  2011-04-15       Impact factor: 3.673

3.  Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.

Authors:  H Einsele; S Knop; M Vogel; J Müller; M Kropff; B Metzner; C Langer; H Sayer; W Jung; H A Dürk; H Salwender; H Wandt; F Bassermann; M Gramatzki; W Rösler; H-H Wolf; W Brugger; M Engelhardt; T Fischer; P Liebisch; C Straka
Journal:  Leukemia       Date:  2017-03-15       Impact factor: 11.528

4.  Apoptosis therapy: driving cancers down the road to ruin.

Authors:  Douglas R Green; Henning Walczak
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

Review 5.  Multiple myeloma: from front-line to relapsed therapies.

Authors:  Philippe Moreau; Cyrille Touzeau
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

6.  Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM.

Authors:  Philippe Moreau; Asher Chanan-Khan; Andrew W Roberts; Amit B Agarwal; Thierry Facon; Shaji Kumar; Cyrille Touzeau; Elizabeth A Punnoose; Jaclyn Cordero; Wijith Munasinghe; Jia Jia; Ahmed Hamed Salem; Kevin J Freise; Joel D Leverson; Sari Heitner Enschede; Jeremy A Ross; Paulo C Maciag; Maria Verdugo; Simon J Harrison
Journal:  Blood       Date:  2017-08-28       Impact factor: 22.113

7.  Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.

Authors:  Monika Engelhardt; Sandra Maria Dold; Gabriele Ihorst; Alexander Zober; Mandy Möller; Heike Reinhardt; Stefanie Hieke; Martin Schumacher; Ralph Wäsch
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

8.  Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.

Authors:  Shaji Kumar; Jonathan L Kaufman; Cristina Gasparetto; Joseph Mikhael; Ravi Vij; Brigitte Pegourie; Lofti Benboubker; Thierry Facon; Martine Amiot; Philippe Moreau; Elizabeth A Punnoose; Stefanie Alzate; Martin Dunbar; Tu Xu; Suresh K Agarwal; Sari Heitner Enschede; Joel D Leverson; Jeremy A Ross; Paulo C Maciag; Maria Verdugo; Cyrille Touzeau
Journal:  Blood       Date:  2017-10-10       Impact factor: 22.113

9.  BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.

Authors:  L Bodet; E Ménoret; G Descamps; C Pellat-Deceunynck; R Bataille; S Le Gouill; P Moreau; M Amiot; P Gomez-Bougie
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

10.  A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.

Authors:  Monika Engelhardt; Anne-Saskia Domm; Sandra Maria Dold; Gabriele Ihorst; Heike Reinhardt; Alexander Zober; Stefanie Hieke; Corine Baayen; Stefan Jürgen Müller; Hermann Einsele; Pieter Sonneveld; Ola Landgren; Martin Schumacher; Ralph Wäsch
Journal:  Haematologica       Date:  2017-02-02       Impact factor: 9.941
View more
  1 in total

1.  Evaluation of Cardiac Function before and after PAD Regimen in Patients with Multiple Myeloma by Three-Dimensional Speckle Tracking Imaging.

Authors:  Dongliang Chen; Zining Yan; Li Fan; Yifei Rui
Journal:  J Healthc Eng       Date:  2022-01-27       Impact factor: 2.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.